Health Products (Licensing of Retail Pharmacies) (Amendment) Regulations 2024

Status:

Published in Subsidiary Legislation Supplement
on 04 Sep 2024

No. S 692

Health Products Act 2007

Health Products
(Licensing of Retail Pharmacies)
(Amendment) Regulations 2024

In exercise of the powers conferred by section 72 of the Health Products Act 2007, the Health Sciences Authority, with the approval of the Minister for Health, makes the following Regulations:

Citation and commencement

1. These Regulations are the Health Products (Licensing of Retail Pharmacies) (Amendment) Regulations 2024 and come into operation on 4 September 2024.

Amendment of regulation 3

2. In the Health Products (Licensing of Retail Pharmacies) Regulations 2016 (G.N. No. S 330/2016), in regulation 3, after paragraph (3), insert —

“(3A) Paragraph (2) does not apply to a holder of a pharmacy licence in respect of —

(a)	the supply by retail sale of influenza vaccines in accordance with the conditions of such supply specified in item 2A of the Third Schedule to the Health Products (Therapeutic Products) Regulations 2016; or
(b)	the supply by retail sale of adrenaline administered using an autoinjector in accordance with the conditions of such supply specified in item 2B of the Third Schedule to the Health Products (Therapeutic Products) Regulations 2016.”.

[G.N. Nos. S 120/2018; S 93/2019; S 106/2021; S 1079/2021; S 455/2022; S 433/2023; S 808/2023]

Made on 29 August 2024.

BENJAMIN ONG

Chairperson,
Health Sciences Authority,
Singapore.

[401:04/01-000; AG/LEGIS/SL/122D/2020/12]

(To be presented to Parliament under section 72(5) of the Health Products Act 2007).

Search within Legislation